Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing.
Cohen D, Hondelink LM, Solleveld-Westerink N, Uljee SM, Ruano D, Cleton-Jansen AM, von der Thüsen JH, Ramai SRS, Postmus PE, Graadt van Roggen JF, Hoppe BPC, Clahsen PC, Maas KW, Ahsmann EJM, Ten Heuvel A, Smedts F, van Rossem RN, van Wezel T. Cohen D, et al. Among authors: von der thusen jh. J Thorac Oncol. 2020 Jun;15(6):1000-1014. doi: 10.1016/j.jtho.2020.01.019. Epub 2020 Jan 31. J Thorac Oncol. 2020. PMID: 32014610 Free article.
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer.
Radonic T, Geurts-Giele WRR, Samsom KG, Roemen GMJM, von der Thüsen JH, Thunnissen E, Meijssen IC, Sleddens HFBM, Dinjens WNM, Boelens MC, Weijers K, Speel EJM, Finn SP, O'Brien C, van Wezel T, Cohen D, Monkhorst K, Roepman P, Dubbink HJ. Radonic T, et al. Among authors: von der thusen jh. J Thorac Oncol. 2021 May;16(5):798-806. doi: 10.1016/j.jtho.2021.01.1619. Epub 2021 Feb 12. J Thorac Oncol. 2021. PMID: 33588111 Free article.
Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer.
Hondelink LM, Hüyük M, Postmus PE, Smit VTHBM, Blom S, von der Thüsen JH, Cohen D. Hondelink LM, et al. Among authors: von der thusen jh. Histopathology. 2022 Mar;80(4):635-647. doi: 10.1111/his.14571. Epub 2021 Nov 16. Histopathology. 2022. PMID: 34786761 Free PMC article.
Real-World Approach for Molecular Analysis of Acquired EGFR Tyrosine Kinase Inhibitor Resistance Mechanisms in NSCLC.
Hondelink LM, Jebbink M, von der Thüsen JH, Cohen D, Dubbink HJ, Paats MS, Dingemans AC, de Langen AJ, Boelens MC, Smit EF, Postmus PE, van Wezel T, Monkhorst K. Hondelink LM, et al. Among authors: von der thusen jh. JTO Clin Res Rep. 2021 Nov 1;2(12):100252. doi: 10.1016/j.jtocrr.2021.100252. eCollection 2021 Dec. JTO Clin Res Rep. 2021. PMID: 34849493 Free PMC article.
The impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer.
Butter R, Hondelink LM, van Elswijk L, Blaauwgeers JLG, Bloemena E, Britstra R, Bulkmans N, van Gulik AL, Monkhorst K, de Rooij MJ, Slavujevic-Letic I, Smit VTHBM, Speel EM, Thunnissen E, von der Thüsen JH, Timens W, van de Vijver MJ, Yick DCY, Zwinderman AH, Cohen D, 't Hart NA, Radonic T. Butter R, et al. Among authors: von der thusen jh. Lung Cancer. 2022 Apr;166:143-149. doi: 10.1016/j.lungcan.2022.03.002. Epub 2022 Mar 5. Lung Cancer. 2022. PMID: 35279453 Free article.
181 results